0H8T fundamentals
An in-depth look to ACLARIS THERAPEUTICS INC USD0.00001 operating, investing, and financing activities
0H8T free cash flow for Q2 24 is -12.31 M USD. For 2023, 0H8T free cash flow was -79.63 M USD and operating cash flow was -78.33 M USD.
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM